Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-16

Clinical Trial Update: Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether tranexamic acid reduces blood transfusion needs in hip fracture surgery; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Mayo Clinic | Conditions: Hip Fracture | Phase 4 | Status: COMPLETED | Results posted: 2016-05-16